
    
      Randomized, multicenter, blinded, two-period cross-over design. Each treatment will last 28
      days. All patients will receive both treatments in a cross-over design, with a wash-out
      period of 14-19 days in between. The total duration of the study for each patient is
      approximately 70 days (from randomization) plus 30 days of safety follow-up.
    
  